Use of tetrahydroisoquinoline compounds for the treatment of septicemia
US6562837B1 · kind B1 · utility
2Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2001 |
| Grant date | May 13, 2003 |
| Priority date | — |
| Expiry date | Mar 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions for the treatment and prophylaxis of heart failure, thrombosis, iNOS-induced tissue injury, septicemia, and disseminated intravascular coagulation. The compositions comprise, as a pharmacologically active ingredient, the compounds represented by the following chemical formulas 1 and 2, each of them showing heart stimulating activity, hypotensive activity, inhibitory activity against platelet aggregation, and suppressive activity against iNOS expression in combination and at once.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.